Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mehy.2006.03.032DOI Listing

Publication Analysis

Top Keywords

improvement anemia
4
anemia pylori
4
pylori eradication
4
eradication patient
4
patient myelodysplastic
4
myelodysplastic syndrome
4
improvement
1
pylori
1
eradication
1
patient
1

Similar Publications

BACKGROUND Arterioportal fistulas (APFs) are abnormal connections between the arterial and portal venous systems, leading to portal hypertension (PH) and symptoms such as gastrointestinal bleeding, splenomegaly, and hepatic pain. Symptoms typically appear by the age of 2 years in about 75% of cases. CASE REPORT A 7-year-old boy with an asymptomatic APF developed life-threatening complications following a Clostridium difficile infection.

View Article and Find Full Text PDF

Factors associated with maternal mortality in Ica, Peru: A matched case-control study.

Medwave

December 2024

Departamento Académico de Ciencias Clínicas, Facultad de Medicina Humana, Universidad Nacional San Luis Gonzaga, Ica, Perú.

Introduction: Maternal mortality remains a significant challenge for public health globally, particularly in developing areas such as Ica, Peru. This study aims to analyze the risk factors contributing to maternal mortality in reference hospitals in Ica during the period of 2010 to 2020.

Methods: A case-control study was conducted, including 49 cases of maternal deaths and 98 controls, applying multivariate logistic regression to analyze data collected from hospital records.

View Article and Find Full Text PDF

Sickle cell disease (SCD) is a prevalent inherited blood disorder, particularly affecting populations in Africa. This review examined the disease's burden, its diverse clinical presentations, and the challenges associated with its management in African settings. Africa bears a significant burden of SCD, with prevalence varying across countries and age groups.

View Article and Find Full Text PDF

Iron deficiency (ID) often coexists with heart failure (HF), and its prevalence increases with the severity of HF. Intravenous ferric carboxymaltose (FCM) has been associated with improvements in clinical outcomes, functional capacity, and quality of life (QoL) in patients with HF and ID. However, while earlier studies showed favorable results, more recent studies have failed to demonstrate significant improvements in outcomes for patients with heart failure with reduced ejection fraction (HFrEF) and ID.

View Article and Find Full Text PDF

Purpose: Daratumumab is a novel, first-in-class monoclonal antibody approved for use as monotherapy and in combination with other treatments for patients with multiple myeloma (MM). The aim of this observational study was to evaluate the effectiveness and safety of daratumumab in real-world clinical practice.

Materials And Methods: This observational multicenter study collected data from patients with MM treated in Korea between June 1, 2018, and February 28, 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!